BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goldman M, Hermans C. Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity. PLoS Med 2021;18:e1003648. [PMID: 34029337 DOI: 10.1371/journal.pmed.1003648] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 27.0] [Reference Citation Analysis]
Number Citing Articles
1 Konstantinou GN. Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating in-silico approach. Hum Vaccin Immunother 2022;18:2050654. [PMID: 35412949 DOI: 10.1080/21645515.2022.2050654] [Reference Citation Analysis]
2 Aliberti L, Gagliardi I, Rizzo R, Bortolotti D, Schiuma G, Franceschetti P, Gafà R, Borgatti L, Cavallo MA, Zatelli MC, Ambrosio MR. Pituitary apoplexy and COVID-19 vaccination: a case report and literature review. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1035482] [Reference Citation Analysis]
3 Carubbi F, Alunno A, Santilli J, Natali L, Mancini B, Di Gregorio N, Del Pinto R, Viscido A, Grassi D, Ferri C. Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares. RMD Open 2022;8:e002460. [DOI: 10.1136/rmdopen-2022-002460] [Reference Citation Analysis]
4 Folegatti PM, Jenkin D, Morris S, Gilbert S, Kim D, Robertson JS, Smith ER, Martin E, Gurwith M, Chen RT; Benefit-Risk Assessment of VAccines by TechnolOgy Working Group BRAVATO, ex-V3SWG). Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment. Vaccine 2022:S0264-410X(22)00755-1. [PMID: 35715352 DOI: 10.1016/j.vaccine.2022.06.008] [Reference Citation Analysis]
5 Abdel Moniem A, Radwan MA, Yousef AI. COVID-19 and cardiovascular disease: Manifestations, pathophysiology, vaccination, and long-term implication. Current Medical Research and Opinion. [DOI: 10.1080/03007995.2022.2078081] [Reference Citation Analysis]
6 Panther EJ, Lucke-Wold B. Subarachnoid hemorrhage: management considerations for COVID-19. Explor Neuroprotective Ther 2022;2:65-73. [PMID: 35340712 DOI: 10.37349/ent.2022.00018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Georgakopoulou VE, Lembessis P, Skarlis C, Gkoufa A, Sipsas NV, Mavragani CP. Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease Outcomes. Front Med 2022;9:850472. [DOI: 10.3389/fmed.2022.850472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Elahi S. Hematopoietic responses to SARS-CoV-2 infection. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04220-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
9 Alnima T, Mulder MMG, van Bussel BCT, Ten Cate H. COVID-19 Coagulopathy: From Pathogenesis to Treatment. Acta Haematol 2022;145:282-96. [PMID: 35499460 DOI: 10.1159/000522498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 López-Martínez R, Albaiceta GM, Amado-Rodríguez L, Cuesta-Llavona E, Gómez J, García-Clemente M, Vázquez-Coto D, Alvarez V, Coto E. The FCGR2Ars1801274 polymorphism was associated with the risk of death among COVID-19 patients. Clin Immunol 2022;:108954. [PMID: 35149195 DOI: 10.1016/j.clim.2022.108954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Favaloro EJ, Pasalic L, Lippi G. Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS. Antibodies 2022;11:7. [DOI: 10.3390/antib11010007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Rees AR. Vaccines are not always perfect: adverse effects and their clinical impact. A New History of Vaccines for Infectious Diseases 2022. [DOI: 10.1016/b978-0-12-812754-4.00016-9] [Reference Citation Analysis]
13 Damoiseaux J, Dotan A, Fritzler MJ, Bogdanos DP, Meroni PL, Roggenbuck D, Goldman M, Landegren N, Bastard P, Shoenfeld Y, Conrad K. Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies. Autoimmun Rev 2021;21:103012. [PMID: 34896650 DOI: 10.1016/j.autrev.2021.103012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 19.0] [Reference Citation Analysis]
14 Mohamed K, Rzymski P, Islam MS, Makuku R, Mushtaq A, Khan A, Ivanovska M, Makka SA, Hashem F, Marquez L, Cseprekal O, Filgueiras IS, Fonseca DLM, Mickael E, Ling I, Arero AG, Cuschieri S, Minakova K, Rodríguez-Román E, Abarikwu SO, Faten AB, Grancini G, Cabral-Marques O, Rezaei N. COVID-19 vaccinations: The unknowns, challenges, and hopes. J Med Virol 2021. [PMID: 34845731 DOI: 10.1002/jmv.27487] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
15 Uaprasert N, Tangcheewinsirikul N, Rojnuckarin P, Patell R, Zwicker JI, Chiasakul T. Heparin-induced thrombocytopenia in patients with COVID-19: a systematic review and meta-analysis. Blood Adv 2021;5:4521-34. [PMID: 34543382 DOI: 10.1182/bloodadvances.2021005314] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
16 Hafeez MU, Ikram M, Shafiq Z, Sarfraz A, Sarfraz Z, Jaiswal V, Sarfraz M, Chérrez-Ojeda I. COVID-19 Vaccine-Associated Thrombosis With Thrombocytopenia Syndrome (TTS): A Systematic Review and Post Hoc Analysis. Clin Appl Thromb Hemost 2021;27:10760296211048815. [PMID: 34698582 DOI: 10.1177/10760296211048815] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
17 McLean-Tooke A, Lucas M, French M. Autoimmunity elicited by the chemokine response to adenovirus vector vaccines may underlie vaccine-induced immune thrombotic thrombocytopaenia: a hypothesis. Clin Transl Immunology 2021;10:e1349. [PMID: 34691454 DOI: 10.1002/cti2.1349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lippi G, Favaloro EJ. Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More. Semin Thromb Hemost 2021. [PMID: 34695859 DOI: 10.1055/s-0041-1736168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
19 Kircheis R. Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways. Int J Mol Sci 2021;22:10791. [PMID: 34639132 DOI: 10.3390/ijms221910791] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
20 Kashir J, Ambia AR, Shafqat A, Sajid MR, AlKattan K, Yaqinuddin A. Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine-induced thrombotic thrombocytopenia (VITT). J Leukoc Biol 2021. [PMID: 34467562 DOI: 10.1002/JLB.5COVR0621-320RR] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
21 Nappi F, Iervolino A, Avtaar Singh SS. COVID-19 Pathogenesis: From Molecular Pathway to Vaccine Administration. Biomedicines 2021;9:903. [PMID: 34440107 DOI: 10.3390/biomedicines9080903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
22 Dhillon P, Altmann D, Male V. COVID-19 vaccines: what do we know so far? FEBS J 2021;288:4996-5009. [PMID: 34288409 DOI: 10.1111/febs.16094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Nasonov EL, Lila AM, Mazurov VI, Belov BS, Karateev AE, Dubinina TV, Nikitinskaya OA, Baranov AA, Abdulganieva DI, Moiseev SV, Zagrebneva AI. Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia. Naučno-praktičeskaâ revmatologiâ 2021;59:239-254. [DOI: 10.47360/1995-4484-2021-239-254] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 21.0] [Reference Citation Analysis]
24 Cimolai N. Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19. SN Compr Clin Med 2021;:1-16. [PMID: 34179695 DOI: 10.1007/s42399-021-00992-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]